Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
L
328130
vs
K
KOSPI 200
Over the past 12 months, Lunit Inc has underperformed KOSPI 200, delivering a return of -29% compared to KOSPI 200's +50% growth.
Stocks Performance
328130 vs KOSPI 200
Performance Gap
328130 vs KOSPI 200
Performance By Year
328130 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Lunit Inc
Glance View
Lunit Inc. is a medical artificial intelligence company that builds software for reading medical images and helping doctors spot disease earlier. Its main products analyze scans such as chest X-rays, mammograms, and pathology images, giving hospitals and clinics a second set of eyes when they review patients for cancer and other serious conditions. The company sells its software to hospitals, imaging centers, and other healthcare providers, and it also works with medical device makers and research partners. Lunit usually earns money by licensing its AI tools, charging subscription or usage-based fees, and entering commercial agreements that put its software inside imaging workflows or partner products. What makes Lunit different is that it sits between healthcare and software: it is not a drug company or a hospital chain, but a provider of diagnostic AI that helps medical teams make faster, more consistent decisions from images. Its business depends on getting its algorithms into routine clinical use and becoming part of the tools doctors already use to detect and manage disease.